Back to All Topics
Mitochondrial
Research Article
2 min read
MOTS-c Metabolic Regulation
Mechanisms by which MOTS-c influences glucose and lipid metabolism.
Introduction
MOTS-c is a mitochondrial-derived peptide with significant metabolic regulatory functions.
MOTS-c Origin and Discovery
Mitochondrial-Derived Peptide
| Feature | Description |
|---|---|
| Origin | Mitochondrial genome (12S rRNA) |
| Size | 16 amino acids |
| Discovery | 2015 |
| Classification | Mitochondrial-derived peptide |
Metabolic Mechanisms
AMPK Pathway
| Step | Event | Metabolic Effect |
|---|---|---|
| 1 | MOTS-c enters cell | Cellular uptake |
| 2 | AMPK activation | Energy sensor triggered |
| 3 | Glucose uptake increased | Improved utilization |
| 4 | Fat oxidation enhanced | Lipid metabolism |
| 5 | Mitochondrial activity | Energy production |
Glucose Metabolism
| Effect | Mechanism | Outcome |
|---|---|---|
| Increased uptake | GLUT4 translocation | Lower blood glucose |
| Improved sensitivity | Enhanced insulin signaling | Better regulation |
| Glycogen storage | AMPK effects | Muscle glycogen |
Lipid Metabolism
| Effect | Mechanism | Outcome |
|---|---|---|
| Fat oxidation | CPT1 activation | Fat burning |
| Lipogenesis reduction | ACC inhibition | Less fat storage |
| Adipose effects | Browning potential | Thermogenesis |
Age-Related Changes
| Age Group | MOTS-c Levels | Metabolic Status |
|---|---|---|
| Young | Higher | Better function |
| Middle-aged | Declining | Variable |
| Elderly | Lowest | Metabolic decline |
Therapeutic Potential
Metabolic Conditions
| Condition | MOTS-c Rationale | Evidence |
|---|---|---|
| Type 2 diabetes | Glucose regulation | Animal data |
| Obesity | Fat metabolism | Animal data |
| Metabolic syndrome | Multiple benefits | Theoretical |
| Aging | Declining levels | Observational |
Exercise Synergy
| Combination | Expected Outcome |
|---|---|
| MOTS-c + endurance exercise | Enhanced metabolic adaptation |
| MOTS-c + fasting | AMPK synergy |
| MOTS-c + low-carb diet | Fat oxidation focus |
Current Research Status
| Aspect | Status |
|---|---|
| Animal efficacy | Demonstrated |
| Human trials | Very limited |
| Safety | Being established |
| Optimal dosing | Unknown |
| Availability | Research only |
Conclusion
MOTS-c represents promising metabolic peptide but requires more human research.
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.